TY - JOUR T1 - Childhood deprivation and Health related quality of life and associated factors among Pediatric cancer patients at National Hospital, Tanzania JF - medRxiv DO - 10.1101/2022.10.26.22281579 SP - 2022.10.26.22281579 AU - Mwanaheri Chubi AU - Stephen Kibusi AU - Lulu Chirande AU - Shakiru Juma Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/11/01/2022.10.26.22281579.abstract N2 - Introduction Pediatrics cancer is one of the most important life-threatening, non-communicable diseases worldwide. However, pediatric cancer patients suffer from physical disabilities associated with cancer treatment. However, there is unclear information about level of health-related quality of life and associated factors. Aimed of this study was to assess level of Health-Related Quality of Life among pediatric cancer patients.Methods A hospital-based Analytical cross-sectional study design with a quantitative approach was employed among 91 conveniently sampled pediatric cancer patients with their parents/caregivers. Self-administered questionnaires were used to collect data. Data were analyzed using SPSS computer software program version 25. One-way ANOVA and linear regression were used to quantify and establish an association between Childhood Deprivation, Health-Related Quality of Life, and associated factors among Pediatric Cancer Patients at 95% CI, and a 5% level of significance.Results Results, the response rate was 92.3% (n = 84). The most prominent kind of pediatric cancer was Acute Lymphoblastic Leukemia 30 (35.7%) and Hodgkin lymphoma 11(13%). The mean age of pediatric cancer patients was 10.26±3.90 years while 59 (70.2%) were male. In linear regression, Childhood Deprivation (β=-1.640; P-value< 0.05) on PedsQL™ 4.0 and (β= -2.175; P-value< 0.01) on PedsQL™ 3.0. Findings imply that decreases the level of Childhood Deprivation, the chance of improving Quality of life increases.Conclusion The magnitude of acute lymphoblastic leukemia is higher among pediatric cancer patients. There was a significant link between pediatric cancers and childhood deprivation and thus, compromised quality of life. Innovative pediatric cancer care policies, guidelines, and or strategies may need to be advocated to address the problem accordingly.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthe author(s) received no specific funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Permission to conduct the study was brought from the University of Dodoma through the Institution Research Review Ethcs Committee (IRREC), and the Executive director of Muhimbili National Hospital, Tanzania to allow the study to be conducted at the oncology unit. The informed consent form was obtained from parents/caregivers and assent was obtained from pediatric cancer patients by the Principle Investigator before being interviewed. No names of participants was appearing on the questionnaire, only numbers were coded to ensure confidentiality. The data collection procedure was conducted in an unoccupied separate room to ensure privacy. The participants had the right to withdraw from the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and Supporting Information files ER -